What It Means if You Have Borderline High Cholesterol—And What to Do About It
It’s an in-between place that’s not quite high, but not quite within a normal range.
It’s an in-between place that’s not quite high, but not quite within a normal range.
Despite a greater CAC increase with high dose and long-term statin therapy, events did not occur more frequently in statin treated patients. This suggests that…
AliveCor announced new study results backing its handheld ECG technology at Heart Rhythm Society 2024 in Boston.
We discuss recent findings from a study by Osei et al. of 28,000 participan ts from the CAC Consortium. In statins users, both the CAC…
WBAP News Radio Dallas/Fort Worth asked Cardiologist Dr. Fahmi Farah, MD to come on the air for a live interview on 5/13/24. Contact Dr. Farah:https://bentle…
This feature about an attending preparing for her upcoming week of service offers a case vignette accompanied by two essays, one supporting visiting patients early…
Monday, May 20, 2024, is FAITH! Heart Health Day in Rochester. The proclamation builds upon the work of Rochester community members who research and do…
The American Heart Association/American College of Cardiology Guidelines for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy published in 2020 have been updated for 2024 to…
In the United States, the high and rising cost of prescription medications has had devastating consequences for many older adults with cardiovascular disease. High out-of-pocket…
The presentation of pulmonary embolism (PE) varies from asymptomatic to life-threatening, and management involves multiple specialists. Timely diagnosis of PE is based on clinical presentation,…
ABSTRACTBackgroundIn nonobstructive hypertrophic cardiomyopathy (nHCM), there are no approved medical therapies. Impaired myocardial energetics is a potential cause of symptoms and exercise limitat…